Mu, Y.;                     Ren, X.-H.;                     Han, D.;                     Guan, Y.-Y.;                     Liu, P.-L.;                     Cheng, S.-X.;                     Liu, H.    
        Codelivery of HBx-siRNA and Plasmid Encoding IL-12 for Inhibition of Hepatitis B Virus and Reactivation of Antiviral Immunity. Pharmaceutics 2022, 14, 1439.
    https://doi.org/10.3390/pharmaceutics14071439
    AMA Style
    
                                Mu Y,                                 Ren X-H,                                 Han D,                                 Guan Y-Y,                                 Liu P-L,                                 Cheng S-X,                                 Liu H.        
                Codelivery of HBx-siRNA and Plasmid Encoding IL-12 for Inhibition of Hepatitis B Virus and Reactivation of Antiviral Immunity. Pharmaceutics. 2022; 14(7):1439.
        https://doi.org/10.3390/pharmaceutics14071439
    
    Chicago/Turabian Style
    
                                Mu, Yan,                                 Xiao-He Ren,                                 Di Han,                                 Ying-Ying Guan,                                 Pei-Ling Liu,                                 Si-Xue Cheng,                                 and Hong Liu.        
                2022. "Codelivery of HBx-siRNA and Plasmid Encoding IL-12 for Inhibition of Hepatitis B Virus and Reactivation of Antiviral Immunity" Pharmaceutics 14, no. 7: 1439.
        https://doi.org/10.3390/pharmaceutics14071439
    
    APA Style
    
                                Mu, Y.,                                 Ren, X.-H.,                                 Han, D.,                                 Guan, Y.-Y.,                                 Liu, P.-L.,                                 Cheng, S.-X.,                                 & Liu, H.        
        
        (2022). Codelivery of HBx-siRNA and Plasmid Encoding IL-12 for Inhibition of Hepatitis B Virus and Reactivation of Antiviral Immunity. Pharmaceutics, 14(7), 1439.
        https://doi.org/10.3390/pharmaceutics14071439